Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively introduce a medical device company with a patented mobile IV Therapy system. This innovative company is dedicated to revolutionizing the delivery of life-saving intravenous (IV) fluids. Originally created to meet critical battlefield needs, the company has since expanded to serve a wide range of markets including emergency response, hospitals, athletics, veterinary care, and global humanitarian missions.

Product Description

Their patented system makes IV fluid delivery fully mobile without the risk of air embolisms and delivers these fluids up to 2.5 times faster than traditional systems. This system functions in any patient position or transport condition, is compatible with warming devices, and can be used by a single provider, simplifying emergency triage.

Market Overview and Future Vision

The IV therapy and access market is projected to exceed $54 billion globally, and the product addresses a $10.9 billion Total Addressable Market (TAM) annually across multiple segments.

The company sits at a pivotal growth point with patented technology, minimal public exposure, and broad market applicability. Next steps include:

• Completing FDA and CE approvals

• Expanding partnerships with the U.S. government and Tier-1 universities

• Launching commercial production

• Entering international and high-growth sectors such as sports therapy and global aid.

Investment Opportunity and Valuation

The owners are seeking an investor with the capital necessary to help them clear FDA approval, complete R&D, & initiate manufacturing. They will consider various deal structures and are open to discussion about valuation.